No Data
No Data
Analysts Have Lowered Expectations For Standard BioTools Inc. (NASDAQ:LAB) After Its Latest Results
Standard BioTools Inc. Faces Revenue Decline Amid Market Challenges
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Shares Fall After Downgrade From KeyBanc
Standard BioTools Analyst Ratings
Express News | Standard BioTools Down 8.6% Premarket After Wider-Than-Forecast Q4 Loss
Unlock the Full List